Oregon Health and Science University
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
Oregon Health and Science UniversityMail Code OC9C; 3181 SW Sam Jackson Park Rd
Portland, , 97239
Portland, , 97239
Website : https://www.ohsu.edu/knight-cancer-institute/bone-marrow-and-stem-cell-transplant
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Number performed | 22 | 49 (14 research; 35 commercial) | 51 | 71 | - |
Medical Director
| Name | Phone |
|---|---|
| Rachel Cook, MD, MS | (503) 494-8426 |
Physician
| Name | Phone |
|---|---|
| Andy Chen, MD, PhD | (503) 494-5058 |
| Amrita Desai, MD | (503) 346-0174 |
| Brandon Hayes-Lattin, MD | (503) 494-1551 |
| Jessica Leonard, MD | (503) 494-4335 |
| Richard Maziarz, MD | (503) 494-1551 |
Coordinator
| Name | Phone |
|---|---|
| Rachel Bixler, RN | (503) 494-5058 |
| Bashi Ratterree, RN, BSN | (503) 494-9982 |
| Jackie Thurman, RN | (503) 494-2235 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Carvykti (ciltacabtagene autoleucel, cita-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)